BACKGROUND: TO know the prevalence of HCV infection in patients diagnosed w
ith B-NHL in our area.
PATIENTS AND METHOD: A group Of patients diagnosed with B-NHL between 1998-
99 were carefully reviewed (serological tests, HCV RNA, laboratory studies,
toxicity, response to treatment and evolution) in a transversal study.
RESULTS: Overall 9/77 (11.68%) Of patients tested positive for HCV. Of the
9 patients HCV(+) showed abnormal elevated transaminases in opposition with
10.3% of patients that tested seronegative.
CONCLUSION: Compared with normal individuals, we have seen a higher prevale
nce of HCV in our S-NHL patients. It may be possible that HCV play a role i
n that lymphoma's pathogenesis.